BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32990022)

  • 1. Heparin-Induced Thrombocytopenia in Severe COVID-19.
    Daviet F; Guervilly C; Baldesi O; Bernard-Guervilly F; Pilarczyk E; Genin A; Lefebvre L; Forel JM; Papazian L; Camoin-Jau L
    Circulation; 2020 Nov; 142(19):1875-1877. PubMed ID: 32990022
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin-Induced Thrombocytopenia in COVID-19.
    Lingamaneni P; Gonakoti S; Moturi K; Vohra I; Zia M
    J Investig Med High Impact Case Rep; 2020; 8():2324709620944091. PubMed ID: 32720827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019.
    Ogawa Y; Nagata T; Akiyama T; Nishida K; Kumasawa J; Kohno M; Kohata H; Gohma I
    J Thromb Thrombolysis; 2020 Nov; 50(4):1012-1014. PubMed ID: 32780355
    [No Abstract]   [Full Text] [Related]  

  • 4. Establishment and Management of Mechanical Circulatory Support During the COVID-19 Pandemic.
    Pham DT; Toeg H; De Paulis R; Atluri P
    Circulation; 2020 Jul; 142(1):10-13. PubMed ID: 32364404
    [No Abstract]   [Full Text] [Related]  

  • 5. Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients With Severe COVID-19 in Wuhan.
    Ren B; Yan F; Deng Z; Zhang S; Xiao L; Wu M; Cai L
    Circulation; 2020 Jul; 142(2):181-183. PubMed ID: 32412320
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperbaric oxygen treatment of novel coronavirus (COVID-19) respiratory failure.
    Harch PG
    Med Gas Res; 2020; 10(2):61-62. PubMed ID: 32541128
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.
    Dragonetti D; Guarini G; Pizzuti M
    Blood Transfus; 2020 Jul; 18(4):328. PubMed ID: 32697931
    [No Abstract]   [Full Text] [Related]  

  • 8. Venous thromboembolism in non-critically ill patients with COVID-19 infection.
    Trimaille A; Curtiaud A; Marchandot B; Matsushita K; Sato C; Leonard-Lorant I; Sattler L; Grunebaum L; Ohana M; Von Hunolstein JJ; Andres E; Goichot B; Danion F; Kaeuffer C; Poindron V; Ohlmann P; Jesel L; Morel O
    Thromb Res; 2020 Sep; 193():166-169. PubMed ID: 32707275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms involved in the development of thrombocytopenia in patients with COVID-19.
    Zhang Y; Zeng X; Jiao Y; Li Z; Liu Q; Ye J; Yang M
    Thromb Res; 2020 Sep; 193():110-115. PubMed ID: 32535232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe COVID-19 infection associated with endothelial activation.
    Escher R; Breakey N; Lämmle B
    Thromb Res; 2020 Jun; 190():62. PubMed ID: 32305740
    [No Abstract]   [Full Text] [Related]  

  • 11. Sudden severe thrombocytopenia in a patient in the recovery stage of COVID-19.
    Chen W; Yang B; Li Z; Wang P; Chen Y; Zhou H
    Lancet Haematol; 2020 Aug; 7(8):e624. PubMed ID: 32464105
    [No Abstract]   [Full Text] [Related]  

  • 12. Applicability of bedside ultrasonography for the diagnosis of deep venous thrombosis in patients with COVID-19 and treatment with low molecular weight heparin.
    Zhang P; Qu Y; Tu J; Cao W; Hai N; Li S; Qu P; Lv C; Guo R
    J Clin Ultrasound; 2020 Nov; 48(9):522-526. PubMed ID: 32757278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PF4-heparin antibodies during ECMO: incidence, course, and outcomes.
    Laverdure F; Louvain-Quintard V; Kortchinsky T; Rezaiguïa-Delclaux S; Imbert A; Stéphan F
    Intensive Care Med; 2016 Jun; 42(6):1082-3. PubMed ID: 26903478
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute Intestinal Ischemia in a Patient with COVID-19 Infection.
    Singh B; Mechineni A; Kaur P; Ajdir N; Maroules M; Shamoon F; Bikkina M
    Korean J Gastroenterol; 2020 Sep; 76(3):164-166. PubMed ID: 32969365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 as a STING disorder with delayed over-secretion of interferon-beta.
    Berthelot JM; Lioté F
    EBioMedicine; 2020 Jun; 56():102801. PubMed ID: 32454408
    [No Abstract]   [Full Text] [Related]  

  • 16. Managing patients with hematological malignancies during COVID-19 pandemic.
    Sahu KK; Cerny J
    Expert Rev Hematol; 2020 Aug; 13(8):787-793. PubMed ID: 32580592
    [No Abstract]   [Full Text] [Related]  

  • 17. Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.
    Beun R; Kusadasi N; Sikma M; Westerink J; Huisman A
    Int J Lab Hematol; 2020 Jun; 42 Suppl 1(Suppl 1):19-20. PubMed ID: 32311843
    [No Abstract]   [Full Text] [Related]  

  • 18. New York City Innocence Lost: Cardiology in the COVID-19 Pandemic.
    Narula N; Singh HS
    Circulation; 2020 Jun; 141(25):2039-2041. PubMed ID: 32255370
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 and lung pathology.
    Jain A
    Indian J Pathol Microbiol; 2020; 63(2):171-172. PubMed ID: 32317509
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidence of heparin-induced thrombocytopenia in patients with 2019 coronavirus disease.
    Lozano R; Franco ME
    Med Clin (Barc); 2020 Nov; 155(9):409-410. PubMed ID: 32883507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.